Sep 11, 2026 08:30AM
Aug 27, 2026 09:01AM
Aug 14, 2026 08:30AM
Jul 31, 2026 10:12AM
Jul 31, 2026 10:12AM
Jul 31, 2026 08:10AM
Jul 31, 2026 08:10AM Moleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients
Jul 6, 2026 08:33AM
Jul 6, 2026 08:33AM
Jul 6, 2026 08:33AM
Jun 30, 2026 08:30AM
Jun 30, 2026 08:30AM
Jun 5, 2026 08:29AM
Jun 5, 2026 08:29AM Independent Market Research Finds Strong Physician Intent to Prescribe Moleculin's Annamycin in Relapsed/Refractory AML
Jun 4, 2026 08:31AM
May 29, 2026 08:21AM
May 21, 2026 05:02PM
May 21, 2026 05:02PM
May 15, 2026 08:30AM
May 13, 2026 08:03AM
May 13, 2026 08:00AM Moleculin Announces Imminent MIRACLE Trial Unblinding as Blinded Data Continue to Significantly Outperform Historical Benchmarks
May 12, 2026 09:30AM
May 12, 2026 09:30AM
May 12, 2026 09:30AM
May 8, 2026 08:45AM
May 8, 2026 08:45AM
Apr 23, 2026 08:27AM
Apr 23, 2026 08:25AM Moleculin’s Annamycin Extends Survival by More Than 60% in Metastatic Pancreatic Cancer Preclinical Models - Data Presented at AACR 2026
Apr 21, 2026 08:36AM
Apr 7, 2026 12:52PM
Apr 7, 2026 08:42AM
Apr 7, 2026 08:36AM
Apr 7, 2026 08:36AM
Mar 23, 2026 08:33AM
Mar 23, 2026 08:31AM Moleculin Hits 45 Subject Enrollment Milestone, Triggering Final Countdown to Mid-2026 MIRACLE Trial Data Readout
Mar 23, 2026 08:31AM
Mar 19, 2026 08:36AM
Mar 17, 2026 09:05AM
Mar 11, 2026 09:00AM
Mar 11, 2026 09:00AM
Feb 19, 2026 08:39AM
Feb 19, 2026 08:39AM Moleculin Announces Exercise of Warrants for $8.3 Million Gross Proceeds
Feb 18, 2026 08:20AM
Feb 18, 2026 08:20AM
Feb 17, 2026 08:35AM
Feb 17, 2026 08:35AM
Feb 13, 2026 08:35AM
Feb 13, 2026 08:32AM
Feb 5, 2026 09:15AM Moleculin to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
Jan 13, 2026 08:55AM

330,737 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All